Skip to Main Content

Author Details

Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
2009
91
49
PMIDPaper TitleJournal TitlePublished Year
34716780Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?Eur Radiol2022
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
33879555PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies.Mol Cancer Ther2021
33446805SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms.Sci Rep2021
32483290Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.Nat Genet2020
33298926TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts.Nat Commun2020
30649385The Genomic Landscape of Mucinous Breast Cancer.J Natl Cancer Inst2019
31754629Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancers.NPJ Breast Cancer2019
32914032Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer.JCO Precis Oncol2019
30185420Lobular Carcinomas <i>In Situ</i> Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.Clin Cancer Res2019
30201825Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma.Mol Cancer Res2019
31527224Distinct Transcriptional Programming Drive Response to MAPK Inhibition in <i>BRAF</i> <sup>V600</sup>-Mutant Melanoma Patient-Derived Xenografts.Mol Cancer Ther2019
30675516Assessment of <i>HMGA2</i> and <i>PLAG1</i> rearrangements in breast adenomyoepitheliomas.NPJ Breast Cancer2019
28921573Contralateral breast cancers: Independent cancers or metastases?Int J Cancer2018
29975246The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.Am J Surg Pathol2018
29854292Somatic mutations in early onset luminal breast cancer.Oncotarget2018
30166553Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.Nat Commun2018
28391513Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.Pathol Oncol Res2018
29739933Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.Nat Commun2018
29506079The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.J Natl Cancer Inst2018
29110152Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.Breast Cancer Res Treat2018
29149504MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.J Pathol2018
27713419Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.Mod Pathol2017
28487443HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2<sup>+</sup> Breast Cancer.Clin Cancer Res2017
28165479Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples.Nat Med2017
28351929Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.Clin Cancer Res2017
28153863The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.Clin Cancer Res2017
28267263Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.Mol Oncol2017
28417598Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma.Histopathology2017
29043292Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways.NPJ Breast Cancer2017
29214215Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.NPJ Breast Cancer2017
28972579Reply to Rosen.Mod Pathol2017
28513873Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.Histopathology2017
28736315The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.Am J Pathol2017
27925203The genetic landscape of breast carcinomas with neuroendocrine differentiation.J Pathol2017
26960396The Genomic Landscape of Male Breast Cancers.Clin Cancer Res2016
28721389Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.NPJ Breast Cancer2016
28721388Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.NPJ Breast Cancer2016
26592504Uterine adenosarcomas are mesenchymal neoplasms.J Pathol2016
26497122Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile.Histopathology2016
27913435IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.Cancer Res2016
27491809Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.Mod Pathol2016
26832993Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.J Pathol2016
26806567Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.J Pathol2016
25994018Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.Genome Biol2015
23759937Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.Am J Surg Pathol2013
31528615Fibrosarcoma: a challenging diagnosis.Autops Case Rep2013
2406764914-3-3Ï¿ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.Proc Natl Acad Sci U S A2013
24162157Genomic profiling of histological special types of breast cancer.Breast Cancer Res Treat2013
21509527Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.Breast Cancer Res Treat2012
  • 1 - 50 of 91

Recommended Authors

Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 9
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 4
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 8
Robert Lesurf
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 3
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 9
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 12
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 2
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 8
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 12
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 9
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 4
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 10
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 7
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 4
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 3
David G Huntsman
University of British Columbia
Career Start Year 1994
Number of shared co-authors 19
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 9
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 13
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 18
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 11
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 3
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 15
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 15
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 17
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 11
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 15
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 9

Collaborators

Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 81
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 50
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 27
Charlotte K Y Ng
University of Bern
Co-authored papers 26
Salvatore Piscuoglio
University of Basel
Co-authored papers 24
Alan Mackay
Co-authored papers 21
Kathleen A Burke
Brown University
Co-authored papers 19
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 18
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 17
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 17
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 13
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Luciano G Martelotto
Monash University
Co-authored papers 10
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Co-authored papers 7
Robert A Soslow
Co-authored papers 6
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Rita A Sakr
Universite Libre de Bruxelles
Co-authored papers 5
Jos?? Palacios
Universidad de Alcala
Co-authored papers 5
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 5
David N Brown
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 5
Ronglai Shen
Co-authored papers 4
Tari A King
Co-authored papers 4
Juan P Palazzo
Thomas Jefferson University Hospital
Co-authored papers 3
Huei-Chi Wen
Co-authored papers 3
Mothaffar F Rimawi
Co-authored papers 2
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Release 1.2